Imperial College London

DrSanjayPopat

Faculty of MedicineNational Heart & Lung Institute

Reader in Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 7808 2132s.popat Website

 
 
//

Location

 

Royal Marsden HospitalThe Royal Marsden Hospital

//

Summary

 

Publications

Citation

BibTex format

@article{Popat:2021:10.2217/fon-2021-0608,
author = {Popat, S and Liu, G and Lu, S and Song, G and Ma, X and Yang, JC-H},
doi = {10.2217/fon-2021-0608},
journal = {FUTURE ONCOLOGY},
pages = {4237--4247},
title = {Brigatinib vs Alectinib in Crizotinib-Resistant Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer (ALTA-3)},
url = {http://dx.doi.org/10.2217/fon-2021-0608},
volume = {17},
year = {2021}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AU - Popat,S
AU - Liu,G
AU - Lu,S
AU - Song,G
AU - Ma,X
AU - Yang,JC-H
DO - 10.2217/fon-2021-0608
EP - 4247
PY - 2021///
SN - 1479-6694
SP - 4237
TI - Brigatinib vs Alectinib in Crizotinib-Resistant Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer (ALTA-3)
T2 - FUTURE ONCOLOGY
UR - http://dx.doi.org/10.2217/fon-2021-0608
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000687189800001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL - 17
ER -